SKA1 and neoplasm: Increasing clinical evidence has indicated that poor clinical prognosis, tumor invasion, and metastasis are all connected to increased SKA1 expression in a wide variety of cancers, including non-small cell lung cancer, bladder cancer, and hepatocellular carcinoma [7–9].